This is a separate and still investigational line of research rather than an established use, and it should not be confused with the fat-loss mechanism that the bulk of the clinical work has focused on
Subcutaneous delivery gives slower, steadier blood levels
PMID 33840611
sensitivity changes the starting rung and escalation speed, not the ceiling by itself
animal studies suggest it may support healing of gastric ulcers and damaged intestinal lining Preclinical models suggest it may help modulate inflammation, though this has not been established in controlled human trials Known risks and side effects: Because it is sold as an unregulated research chemical rather than a manufactured pharmaceutical, product purity and dosing accuracy cannot be verified, and the FDA has flagged potential impurities and manufacturing-quality concerns FDA's Category 2 determination specifically cited potential immune reactions and hypersensitivity as a safety concern User-reported (non-clinical-trial) effects include injection-site irritation, redness, or swelling, along with occasional headache, nausea, or lightheadedness, based on anecdotal reporting rather than controlled studies No long-term human safety data exists
